Zimmer Biomet appoints new president, CEO amid leadership changes
Click Here to Manage Email Alerts
Key takeaways:
- Zimmer Biomet announced Ivan Tornos will succeed Bryan Hanson as president and CEO.
- Suketu Upadhyay will oversee global operations and supply chain.
- Christopher Begley has been appointed chair of the board of directors.
Zimmer Biomet Holdings Inc. has announced Ivan Tornos as president and CEO amid a series of leadership changes in the company, according to a press release.
Tornos, who has also been elected to the board of directors, succeeds Bryan Hanson, who served as president and CEO of Zimmer Biomet since 2017. Tornos most recently served as chief operating officer of the company since 2021. His election to the board and appointment as president and CEO of the company are effective immediately.
“It is an honor to be appointed CEO of Zimmer Biomet at a time when our execution is extremely strong and our innovation momentum is at an all-time high,” Tornos, said in the release. “I am grateful for Bryan’s leadership in transforming the company and am now looking forward to leading the team and accelerating our [Zimmer Biomet] strategy to drive continued growth and boldly advance the standard of musculoskeletal care,” Tornos added.
“The last [5.5] years at the helm of Zimmer Biomet have been transformational, not just for the company, but for me, as well," Hanson, who will be assuming the role of CEO of the health care spinoff of 3M, said in the release. “I have the utmost confidence in Ivan, the entire [Zimmer Biomet] team and the strength of the business. I cannot think of a better leader to continue to move the [Zimmer Biomet] mission forward and deliver value for patients, customers and shareholders,” he said.
The company also announced Suketu (Suky) Upadhyay, chief financial officer and executive vice president of Zimmer Biomet, is expanding his role to oversee global operations and supply chain. In addition, Christopher Begley, lead independent director of Zimmer Biomet, has been appointed chair of the board of directors, according to the release.
“Ivan has consistently delivered strong results since joining Zimmer Biomet. His deep expertise in the [medical technology] sector, commercial prowess and proven leadership experience make him the ideal leader for Zimmer Biomet as we move into our next phase of innovation and growth,” Begley said in the release. “As a board of directors, we are extremely pleased with the strength of the company's succession planning efforts, the depth of the management team and Ivan's appointment. On behalf of the entire board, I thank Bryan for his tremendous service to the organization and his role in establishing the company as a leading player in the [medical technology] space,” Begley said.
Read more about
Click Here to Manage Email Alerts